期刊文献+

米非司酮配合乳酸依沙吖啶应用于中孕引产的临床观察 被引量:5

Clinical observation of mifepristone combined with rivanol used in mildtem pregnancy induced labor
下载PDF
导出
摘要 目的探讨米非司酮配合乳酸依沙吖啶应用于中孕引产的安全性和有效性。方法将中期妊娠要求引产的健康孕妇分成两组,对照组:羊膜腔内注射乳酸依沙吖啶100mg;试验组:加米非司酮片150mg口服。结果米非司酮配合乳酸依沙吖啶引产的孕妇引产开始至胎儿胎盘娩出时间明显缩短,产时出血量减少,清宫率降低。结论二者配伍用药效果显著,减轻产妇疼痛的时间,是一种使用方便、安全、有效、价格便宜的引产方法。 Objective To discuss the safety and efficacy of mifepristone combined with rivanol used in mild-tem preg- nancy induced labor. Methods The mild-tem pregnancy induced labor of healthy pregnant women were divided into two groups, control group: 100 mg of intramuscular injection of rivanol into amniotic cavity; experimental group: add mifepristone tablets 150 mg for oral. Results The time was significantly reduced of pregnant women with mifepristone rivanol odinopoeia note medicine the placenta to the fetus, the intrapartum haemorrhage amount was reduced, uterus clearaning rate was lower. Conclusion The compatibility of drug effect is remarkable, it can reduce the maternal pain time, it is a kind of easy to use, safe, effective and cheap method of induced labor.
出处 《中国当代医药》 2013年第15期67-67,69,共2页 China Modern Medicine
关键词 米非司酮 乳酸依沙吖啶 中期妊娠 引产 Mifepristone Rivanol Second trimester pregnancy Induced labour
  • 相关文献

参考文献9

二级参考文献42

  • 1何晓明,张振钧.人工流产对其后再次妊娠结局的影响[J].中国实用妇科与产科杂志,1996,12(5):287-288. 被引量:30
  • 21,乐杰主编.妇产科学.第4版.北京:人民卫生出版社,1998.324
  • 3[2]Hollis S, Campbell F. What is meant by intention to treat analysis? Survey of published randomized controlled trials. BMJ,1999;319(7211):670.
  • 4[3]WHO Scientific Group. Medical methods for termination of pregnancy. World Health Organ Tech Rep Ser,1997;871:i-vii,1-110.
  • 5[5]Zabin LS,Hirsch MB, Boscia JA. Differential characteristics of adolescent pregnancy test patients: abortion, childbearing and negative test groups. J Adolesc Health Care,1990;11(2):107.
  • 6[6]Creinin MD.Current medical abortion care. Curr Womens Health Rep,2003;3(6):461.
  • 7[8]Pugenbrock JI. The relationship between spontaneous of induced abortion and the occurrence of second-trimester abortion in subsequent pregnancies .Eur J Obstet Gynecol Reprod Biol,1983;14:299.
  • 8[5]Sarkar NN. Mifepristone: bioavailability, pharmacokinetics and useeffectiveness. European Journal of Obstetrics, Gynecology and Reproductive Biology, 2002, 101: 113-120.
  • 9[6]Tang Oishan, Schweer Horst, Seyberth HW, et al. Pharmacokinetics of different routes of administration of misoprostol. Human Reproduction,2002, 17: 332-336.
  • 10[7]Danielsson KG, Marions L, Rodriguez A, et al. Comparison between oral and vaginal administration of misoprostol on uterine contractility. Obstet Gynecol, 1999, 93: 275-280.

共引文献770

同被引文献35

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部